NEU 2.60% $19.47 neuren pharmaceuticals limited

Wilsons target $18.29 and summary, page-64

  1. 174 Posts.
    lightbulb Created with Sketch. 72
    Thing is the current SP is only reflective of Daybue so even if ROW never eventuated and all 4 ph2 trials failed we'd still be sitting around this price or probably more once the profits start rolling in. Fact is NEU is now derisked and apart from a short term tanking in SP should the above happen itll level back out on daybue profits alone. Agree things can and do often go wrong in the stock market but at the bare minimum selling this side of ROW announcement would be like cutting your fingers off. IMO anyway.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.47
Change
-0.520(2.60%)
Mkt cap ! $2.483B
Open High Low Value Volume
$20.10 $20.10 $19.30 $7.022M 360.5K

Buyers (Bids)

No. Vol. Price($)
2 6115 $21.41
 

Sellers (Offers)

Price($) Vol. No.
$17.53 428 1
View Market Depth
Last trade - 15.59pm 09/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.